Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
51 studies found for:    "Camurati-Engelmann disease" [DISEASE] OR NCT00001754 [ID-NUMBER]
Show Display Options
Rank Status Study
21 Recruiting ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer
Condition: Rectal Adenocarcinoma
Interventions: Drug: LY2157299;   Drug: Capecitabine;   Drug: Fluorouracil;   Procedure: Tumor specific mesorectal excision
22 Completed Radiation Therapy in Treating Women With Invasive Breast Cancer
Condition: Breast Cancer
Interventions: Other: laboratory biomarker analysis;   Procedure: adjuvant therapy;   Radiation: radiation therapy
23 Completed Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer
Conditions: Lung Neoplasm;   Carcinoma, Bronchogenic
Intervention: Biological: Lucanix
24 Completed
Has Results
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
Condition: Osteoarthritis, Knee
Interventions: Biological: TissueGene-C;   Drug: Normal Saline
25 Completed Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma
Conditions: Carcinoma, Renal Cell;   Melanoma
Interventions: Biological: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody;   Biological: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ ) Monoclonal Antibody
26 Completed Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)
Condition: Renal Cell Carcinoma
Intervention: Drug: Anti-Transforming Growth Factor-beta (GC 1008)
27 Unknown  PF-03446962 in Relapsed or Refractory Urothelial Cancer
Condition: Transitional Cell Carcinoma of Bladder
Intervention: Drug: PF03446962
28 Active, not recruiting Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy
Condition: Primary Open Angle Glaucoma
Interventions: Drug: TGF-β2 antisense oligonucleotide;   Procedure: Trabeculectomy
29 Completed Effect of Montelukast on Remodelling Markers in Asthmatic Children
Condition: Asthma
Interventions: Drug: Montelukast;   Drug: placebo
30 Recruiting A Study of LY3200882 in Participants With Solid Tumors
Condition: Solid Tumor
Intervention: Drug: LY3200882
31 Active, not recruiting A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: LY2157299;   Drug: Sorafenib;   Drug: Placebo
32 Completed Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males
Condition: Cicatrix
Intervention: Drug: Juvista (avotermin) plus placebo, standard-care (within-subject controls)
33 Completed Prognostic Value of Transforming Growth Factor-Beta 1 in Normal Pressure Hydrocephalus
Condition: Normal Pressure Hydrocephalus
Intervention: Other: CSF collection
34 Recruiting Natural History and Genetics of Food Allergy and Related Conditions
Conditions: Food Allergy;   Loeys-Dietz Syndrome
35 Unknown  Study of Arimidex and Radiotherapy Sequencing
Condition: Breast Cancer
Interventions: Drug: Pre-radiotherapy commencement of Arimidex;   Drug: Post radiotherapy commencement of Arimidex;   Radiation: Radiotherapy
36 Completed Study of Sodium Bicarbonate in Kidney Transplant Recipients
Condition: Kidney Transplantation
Intervention: Drug: Sodium bicarbonate
37 Completed Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals
Conditions: Diabetes Mellitus Type 1;   Diabetes Mellitus Type 2
Intervention: Drug: Sitagliptin (Januvia)
38 Completed A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasms
Intervention: Drug: fenretinide
39 Unknown  Corneal Epitheliotropic Factors in Autologous Serum Eye Drops in Nonautoimmune and Stevens-Johnson Syndrome With Dry Eye
Condition: Stevens-Johnson Syndrome
40 Active, not recruiting
Has Results
Fresolimumab and Radiotherapy in Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Fresolimumab;   Radiation: Radiation Therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-51) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.